These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3547849)

  • 1. Humoral rejection of rat hepatic transplants by passive transfer of serum.
    Knechtle SJ; Kolbeck PC; Tsuchimoto S; Coundouriotis A; Sanfilippo F; Bollinger RR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1072-6. PubMed ID: 3547849
    [No Abstract]   [Full Text] [Related]  

  • 2. Prolonged cold ischemia does not trigger lethal rejection or accelerate the acute rejection in two allogeneic rat liver transplantation models.
    Jin H; Dahmen U; Liu A; Huang H; Gu Y; Dirsch O
    J Surg Res; 2012 Jun; 175(2):322-32. PubMed ID: 21612794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new immunosuppressive drug, brequinar sodium, suppresses liver allograft rejection in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Aug; 25(4):2697-8. PubMed ID: 8356719
    [No Abstract]   [Full Text] [Related]  

  • 4. Brequinar sodium suppresses liver allograft rejection and induces permanent tolerance in the rat.
    Knoop M; Cramer DV; Chapman FC; Makowka L
    Transplant Proc; 1993 Feb; 25(1 Pt 1):706-7. PubMed ID: 8438447
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: the distribution of donor class I-positive cells in the recipient.
    Goto M; Yamaguchi Y; Matsuno K; Takata N; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Otsuka Y; Mori K
    Transplant Proc; 1993 Apr; 25(2):1893-5. PubMed ID: 8470217
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerated rejection of a skin graft after liver transplantation from a sensitized donor: functional aspects of microchimerism.
    Dahmen U; Tanigawa T; Rogiers X; Lindkaer-Jensen S; Broelsch CE
    Transplant Proc; 1996 Dec; 28(6):3243-5. PubMed ID: 8962256
    [No Abstract]   [Full Text] [Related]  

  • 7. Suppression of hepatic allograft rejection in the rat by mitomycin C-treated donor splenocytes: tissue distribution of donor class I major histocompatibility complex antigen-positive cells in the recipient.
    Goto M; Yamaguchi Y; Hamaguchi H; Hisama N; Miyanari N; Ichiguchi O; Mori K; Shirakusa T; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1625-7. PubMed ID: 7725428
    [No Abstract]   [Full Text] [Related]  

  • 8. A serine protease inhibitor, N-alpha-tosyl-l-lysine chloromethyl ketone, prolongs rat hepatic allograft survival.
    Zhang JL; Yamaguchi Y; Mori K; Okabe K; Hidaka H; Ohshiro H; Uchino S; Ishihara K; Furuhashi T; Yamada S; Ogawa M
    J Surg Res; 2001 Apr; 96(2):296-303. PubMed ID: 11266287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A passive transfer model of hyperacute rat cardiac allograft rejection.
    Forbes RD; Guttmann RD; Pinto-Blonde M
    Lab Invest; 1979 Oct; 41(4):348-55. PubMed ID: 385979
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of serum IL-8 concentrations after orthotopic liver transplantation in rats.
    Yagihashi A; Zou XM; Hirata K; Asanuma K; Tsuruma T; Matsuno T; Yamaguchi H; Yamashiro K; Koide S; Torimoto K
    Transplant Proc; 1995 Apr; 27(2):1632-3. PubMed ID: 7725431
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of class I antigens in hyperacute rejection of hepatic allografts in rats.
    Knechtle SJ; Yamaguchi Y; Harland RC; Coundouriotis A; Bollinger RR
    Transplant Proc; 1989 Jun; 21(3):3557. PubMed ID: 2662529
    [No Abstract]   [Full Text] [Related]  

  • 12. [Involvement of ICAM-1/LFA-1 adhesion molecule set in rat orthotopic liver transplantation].
    Omura T
    Hokkaido Igaku Zasshi; 1994 Sep; 69(5):1220-31. PubMed ID: 7868060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model.
    Nakamura K; Murase N; Becich MJ; Furuya T; Todo S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 May; 142(5):1383-91. PubMed ID: 8494042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of hyperimmune alloantiserum in allograft survival.
    Oluwasanmi JO
    Immunology; 1973 Nov; 25(5):881-9. PubMed ID: 4586741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte regeneration during liver allograft rejection in the rat.
    Takata N; Yamaguchi Y; Goto M; Makino Y; Kikuchi N; Hamaguchi H; Hisama N; Otsuka Y; Mori K; Ogawa M
    Transplant Proc; 1993 Apr; 25(2):1975-7. PubMed ID: 8470249
    [No Abstract]   [Full Text] [Related]  

  • 16. The efficiency of humoral immune transfer depends on both the graft and the immunosuppressive treatment.
    Dahmen U; Li J; Gu Y; Doebel L; Fan LM; Polywka S; Dirsch O; Broelsch CE
    Transpl Int; 2003 Mar; 16(3):161-7. PubMed ID: 12664210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of "high" and "low" doses of humoral antibodies on allotransplanted tissue in inbred rats.
    Ishikawa M
    Transplantation; 1981 May; 31(5):402-3. PubMed ID: 7015631
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyperacute rejection of liver transplants in rats.
    Knechtle SJ; Kolbeck P; Tsuchimoto S; Sanfilippo F; Bollinger RR
    Curr Surg; 1986; 43(4):303-5. PubMed ID: 3527575
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferative activity in the splenic compartment during hepatic allograft rejection in the rat.
    Yamaguchi Y; Misumi M; Hisama N; Miyanari N; Hamaguchi H; Ichiguchi O; Goto M; Mori K; Ogawa M
    Transplant Proc; 1995 Apr; 27(2):1614-6. PubMed ID: 7725424
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of ongoing liver graft rejection by administration of serum from liver-transplanted rats.
    Sumimoto R; Kamada N
    Transplant Proc; 1989 Feb; 21(1 Pt 1):431-2. PubMed ID: 2650166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.